Imdelltra Alternatives Compared
Imdelltra | Etoposide | Durvalumab |
|
---|
Imdelltra (tarlatamab) | Etoposide | Durvalumab |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Small Cell Lung Cancer. Imdelltra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Small Cell Lung Cancer, Ovarian Cancer, Cancer, Hodgkin's Lymphoma, Multiple Myeloma, Testicular Cancer. etoposide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Non Small Cell Lung Cancer, Small Cell Lung Cancer, Biliary Tract Tumor, Hepatocellular Carcinoma, Endometrial Cancer. durvalumab may also be used for purposes not listed in this... View more |
Related suggestions Small Cell Lung Cancer
|
|||||||||||||||
More about Imdelltra | More about Etoposide | More about Durvalumab | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Durvalumab has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: etoposide side effects in more detail. |
See also: durvalumab side effects in more detail. |
|||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Imdelltra prices |
View all etoposide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Etopophos, Toposar | Imfinzi | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
636 hours |
11 hours |
408 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 341 drugs are known to interact with Imdelltra:
|
A total of 443 drugs are known to interact with etoposide:
|
A total of 157 drugs are known to interact with durvalumab:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
May 16, 2024 |
December 30, 1986 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.